Reduction in standard cancer screening in 2020 throughout the US

LK Dennis, CH Hsu, AK Arrington - Cancers, 2021 - mdpi.com
Simple Summary The COVID-19 pandemic has had a significant impact on health care
including cancer screening. We examined 2020 compared to the 2014–2019 cancer …

Changes in cancer screening in the US during the COVID-19 pandemic

SA Fedewa, J Star, P Bandi, A Minihan, X Han… - JAMA network …, 2022 - jamanetwork.com
Importance Health care was disrupted in the US during the first quarter of 2020 with the
emergence of the COVID-19 pandemic. Early reports in selected samples suggested that …

Association of cancer screening deficit in the United States with the COVID-19 pandemic

RC Chen, K Haynes, S Du, J Barron, AJ Katz - JAMA oncology, 2021 - jamanetwork.com
Importance The COVID-19 pandemic led to sharp declines in cancer screening. However,
the total deficit in screening in the US associated with the pandemic and the differential …

The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: a large US academic center analysis

FO Marcondes, D Cheng, ET Warner, SC Kamran… - Preventive …, 2021 - Elsevier
Cancer screening rates declined sharply early in the COVID-19 pandemic. The impact of the
pandemic may have exacerbated existing disparities in cancer screening due to the …

Cancer screening in the United States during the second year of the COVID-19 pandemic

J Star, P Bandi, RL Siegel, X Han, A Minihan… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To examine whether cancer screening prevalence in the United States during
2021 has returned to prepandemic levels using nationally representative data. METHODS …

Cancer screening disparities before and after the COVID-19 pandemic

AK Lofters, F Wu, E Frymire, T Kiran… - JAMA Network …, 2023 - jamanetwork.com
Importance Breast, cervical, and colorectal cancer–screening disparities existed prior to the
COVID-19 pandemic, and it is unclear whether those have changed since the pandemic …

Cancer screening in the US through the COVID-19 pandemic, recovery, and beyond

JM Croswell, DA Corley, JE Lafata, JS Haas… - Preventive …, 2021 - Elsevier
COVID-19 has proved enormously disruptive to the provision of cancer screening, which
does not just represent an initial test but an entire process, including risk detection …

COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States

A DeGroff, J Miller, K Sharma, J Sun, W Helsel… - Preventive …, 2021 - Elsevier
Women from racial and ethnic minority groups face a disproportionate burden of cervical
and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) …

Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic

C Labaki, Z Bakouny, A Schmidt, SR Lipsitz… - Cancer Cell, 2021 - cell.com
Following the pandemic onset, a dramatic decrease in the number of cancer screening tests
and ensuing diagnoses was observed (Bakouny et al., 2021; Chen et al., 2021; Patt et al …

Cancer screenings during the COVID-19 pandemic: an analysis of public interest trends

B Greiner, S Tipton, B Nelson, M Hartwell - Current problems in cancer, 2022 - Elsevier
Abstract Introduction The Coronavirus Disease 2019 (COVID-19) pandemic has impacted
breast, colon, prostate, and lung cancer screenings in the US by decreasing screening …